Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis by Prendergast, A, Bwakura-Dangarembizi, M, Mugyenyi, P, Lutaakome, J, Kekitiinwa, A, Thomason, M, Gibb, D, Walker, A

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. by Bwakura-Dangarembizi, M, Kendall, L, Bakeera-Kitaka, S, Nahirya-Ntege, P, Keishanyu, R, Nathoo, K, Spyer, M, Kekitiinwa, A, Lutaakome, J, Mhute, T, Kasirye, P, Munderi, P, Musiime, V, Gibb, D, Walker, A, Prendergast, A

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation by Bourke, CD, Gough, EK, Pimundu, G, Shonhai, A, Berejena, C, Terry, L, Baumard, L, Choudhry, N, Karmali, Y, Bwarkura-Dangarembizi, M, Musiime, V, Lutaakome, J, Kekitiinwa, A, Mutasa, K, Szubert, AJ, Spyer, MJ, Deayton, JR, Glass, M, Geum, HM, Pardieu, C, Gibb, DM, Klein, N, Edens, TJ, Walker, AS, Manges, AR, Prendergast, AJ